As a scientific expert in the cannabis industry, I frequently encounter conflicting information about the efficacy and effects of cannabinoids like CBD. My approach is to rely first and foremost on high-quality clinical research to determine a product's likely effects. In some cases, preclinical research in animals or cell models suggests potential benefits that have not yet been proven in humans. In these situations, I consider the quality and relevance of the preclinical work, look for emerging human studies, and determine if the product shows promise for further research. If it does,I may recommend it to customers with the clear caveat that clinical evidence in humans is still limited. For products already on the market, I scrutinize available research to determine the evidence for specific health claims. If research is sparse or inconsistent, I do not recommend the product or only do so cautiously, noting the limitations in evidence. Anecdotes and customer testimonials are not scientifically valid evidence of a product's efficacy. Quality, unbiased research is the gold standard.
As CEO of Zaleaf, a cannabinoid company, I regularly encounter conflicting research on the uses and effects of our products. When studies disagree, I examine the sources and methods to determine the most rigorous and unbiased findings. For example, some early research suggested CBD could help reduce seizures, but other studies found no benefits. We waited for higher-quality clinical trials, which confirmed CBD's anticonvulsant effects, especially in certain forms of epilepsy. We then began developing CBD oils and capsules to help customers managing seizures and other neurological conditions. With Delta-8 THC, a minor cannabinoid we produce, research is limited. Many customers report it produces a mild high with reduced anxiety compared to Delta-9 THC. However, without long-term studies, we can't confirm its safety or conclusively claim psychoactive effects. We are transparent about the lack of research and advise customers to start with a low dose. By tracking customer experiences and watching for new studies, we aim to gain a clearer understanding of Delta-8's impacts. When evidence is mixed or lacking, we rely on high standards of quality and safety. Zaleaf products undergo independent lab testing to verify content and ensure they are free from contaminants. We work closely with medical professionals to evaluate new research and stay up to date with the latest cannabis science and regulations. Our goal is to provide effective, natural options for wellness based on facts, not fads.